Research
-
Completed
April 2021 - May 2023
Development of novel antimicrobial therapy for Acanthamoeba Keratitis
Researchers seek to develop novel HDPs with enhanced efficacy and safety to treat Acanthamoeba Keratitis (AK).
-
Completed
October 2013 - September 2016
The effect of inflammation throughout the body on AMD
Could looking at what’s happening outside the retina in long-term illness shed light on a new approach to treating age-related macular degeneration?
-
Completed
October 2013 - September 2016
Making a vital component of gene therapy for retinitis pigmentosa that can be used in clinical trials
Improving on a treatment that works well in animals with a natural form of severe sight loss
-
Completed
October 2013 - September 2016
Can a moving target help to make the most of peripheral vision?
Exploring new ideas for visual aids to improve life for people with AMD
-
Completed
December 2013 - February 2017
Repairing the retina’s blood supply before sight-threatening damage occurs
Developing a better alternative to anti-VEGF drugs
-
Completed
October 2013 - September 2016
How do cell recycling, inflammation and support cell death link together in dry AMD?
Understanding more about a substance that might proect against wet AMD and also cause the dry form.
-
Completed
December 2013 - December 2016
Developing a safe 'designer drug' to correct the genetic faults behind inherited eye disorders
A clever approach to treatment that could potentially restore sight
-
Completed
October 2014 - September 2018
Can we repair ‘misfolding’ proteins in a common type of retinitis pigmentosa?
Looking for substances that can make the light-detecting pigment rhodopsin more stable.
-
Completed
January 2013 - March 2016
Finding more of the genes that cause inherited blindness that starts in childhood
Aiming for an accurate diagnosis for everyone with Leber congenital amaurosis or early onset severe retinal dystrophy